Genprex

GNPX • NASDAQ • Stock Fundamentals

Genprex is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ryan Confer, with a market cap of $8.2M.

Market Cap$8.2M

Employees25.0

CEORyan Confer

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026

Financials

Based on Q1 2026 filing

Common questions about Genprex

Genprex (GNPX) has a market capitalization of $8.2M and trades on NASDAQ.

Genprex has approximately 25 employees.